Lyxor Asset Management, an exchange-traded fund provider and subsidiary of Societe Generale Group, will list two ETFs on BATS Chi-X Europe’s Regulated Market on 25 November 2013.
The Lyxor UCITS ETF MSCI Emerging Markets (LEMD) will trade in USDs and settle in Euroclear UK & Ireland, while the Lyxor UCITS ETF EURO STOXX 50 (MSE), which will trade in Euros and settle in Euroclear France.
Lyxor is the third-largest ETF provider in Europe with more than USD41bn in ETF assets under management.
BATS Chi-X Europe chief executive Mark Hemsley says: “Lyxor is a leading provider of exchange traded funds in Europe and we are delighted to welcome them to our pan-European listings venue. Lyxor’s decision to list their products on BATS Chi-X Europe underscores our commitment to delivering an efficient, borderless pan-European capital market designed to benefit all market participants.
“With BATS Chi-X Europe’s pan-European reach, we’re able to provide issuers with a neutral single channel to reach a diverse set of investors across Europe, whilst allowing our participants easy access to these innovative products.”
Arnaud Llinas, Lyxor’s head of ETFs and indexing, says: “The partnership with BATS Chi-X Europe reflects our continued commitment to provide European ETF investors with innovative trading solutions. The fragmentation of the European market is a challenge for ETF providers, placing significant restrictions on the liquidity of individual products. By offering a pan-European listing venue, BATS Chi-X Europe is offering us an opportunity to increase liquidity on our products and thereby increase their efficiency. This is an extremely positive development for the ETF industry.”
